Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-08

Clinical Trial Update: Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating whether bupropion with counseling, with or without contingency management, improves smoking cessation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion (Wellbutrin, Zyban) (bupropion)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Cancer Survivor, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: COMPLETED